The resumption of work in Guizhou's peak is progressing smoothly.
Release time:
2020-07-15
As a key investment project in the peak cement sector, Guizhou Huangping Peak Cement Company has made active efforts to resume construction as soon as possible while doing a good job in the prevention and control of the new crown epidemic. Since it was approved to resume work on February 12, project construction and equipment installation have been carried out one after another, and all construction work is basically on the right track.
Traffic and logistics were blocked in most parts of the country due to the impact of the new crown epidemic. In order to resume construction work as soon as possible, on January 30, Guizhou Jianfeng management team returned to the project site to implement epidemic prevention and control and resume construction work, strictly in accordance with the requirements of the group company, aiming at the characteristics of large number of personnel, wide sources and difficult prevention and control in the construction project under construction, combined with relevant documents of Huangping county government, formulated the epidemic prevention and control work plan and emergency plan, and defined the epidemic prevention and control work responsibilities.
Since early February, Guizhou Jianfeng employees and foreign construction personnel have returned one after another. In order to effectively prevent and control the epidemic situation, Guizhou Jianfeng cooperated with the local government to earnestly implement the information investigation of the returning personnel. The returning personnel from other places in Guizhou were strictly carried out in accordance with the procedures of hospital physical examination and 14-day home isolation observation. The temperature of the isolated personnel was measured twice a day in the morning and afternoon to report their health status. At the same time, a service team was set up to deliver meals, thus solving the living needs of the isolated personnel, relieve the psychological pressure of the isolation personnel until the isolation period expires and the body temperature measurement returns to work normally. At the same time, Guizhou Jianfeng has taken many measures to step up publicity efforts, using WeChat groups, posters, slogans and other means to publicize the health science knowledge of novel coronavirus infection pneumonia in a timely manner, and implement prevention and control measures. Intensify investigation efforts, grasp the basic situation of returning personnel, do a good job in registration and investigation, organize health examination, and timely grasp the health conditions of all kinds of personnel; Strengthen personal protection and disinfection and sterilization in office places, protective masks, hand sanitizer and other protective articles were distributed to employees, and offices, canteens, dormitories, toilets and other areas were disinfected and killed daily to cut off the source of infection. The factory area is managed in a closed way, and the entrance and exit personnel are registered and their body temperature is measured. At the same time, non-staff personnel are strictly prohibited from entering the canteen, and measures are taken to eat in batches according to time periods. On February 13, the first batch of construction personnel officially entered the site to resume the construction of deep pressure pump room. With the reduction of the epidemic prevention and control level in Guizhou Province from level 1 to level 3 on February 23, the return of personnel from outsourcing units has accelerated, and various construction work has gradually been on the right track.
As of March 9, the installation of equipment such as Guizhou Jianfeng kiln head power room, limestone power room, general step-down station, raw meal homogenization warehouse, raw material mixing station, firing kiln head and other equipment and the decoration of living quarters have resumed construction one after another, and most of the civil construction has returned to normal. Guizhou peak and outsourcing construction and installation units returned to work with a total of 549 personnel in normal physical condition. During this period, Qiandongnan Prefecture, Huangping County government leaders and relevant persons in charge of many times to Guizhou peak inspection to guide the epidemic protection and resumption of production work, the implementation of Guizhou peak prevention and control measures, the resumption of work to give affirmation. (Pan Yi)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page